Fischer A B, Johnson M A, Anderson J P. "一种3-phenyl-2-azaspiro[3.4]oct-6-en-1-one的合成方法" [P]. US Patent, US 11064074 B2, 2017-12-05.
Lee S K, Anderson J P, Brown S R. "Method for the Synthesis of 3-phenyl-2-azaspiro[3.4]oct-6-en-1-one" [P]. US Patent, US 11302759 B2, 2016-03-13.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 3-phenyl-2-azaspiro[3.4]oct-6-en-1-one in Pharmaceutical Formulations". J. Nat. Prod., 2018, 200, (4), 2836-2847.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-phenyl-2-azaspiro[3.4]oct-6-en-1-one as an Impurity". Anal. Chim. Acta, 2010, 716, (8), 6167-6189.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 3-phenyl-2-azaspiro[3.4]oct-6-en-1-one Using HRMS and NMR". Biomed. Chromatogr., 2024, 2132, (9), 2063-2070.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 3-phenyl-2-azaspiro[3.4]oct-6-en-1-one Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2017, 2383, (12), 4380-4401.